{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cellules A549 : Questions médicales les plus fréquentes",
"headline": "Cellules A549 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cellules A549 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-28",
"dateModified": "2025-03-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cellules A549"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cellules épithéliales",
"url": "https://questionsmedicales.fr/mesh/D004847",
"about": {
"@type": "MedicalCondition",
"name": "Cellules épithéliales",
"code": {
"@type": "MedicalCode",
"code": "D004847",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.436"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Cellules A549",
"alternateName": "A549 Cells",
"code": {
"@type": "MedicalCode",
"code": "D000072283",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Wenfei Zhao",
"url": "https://questionsmedicales.fr/author/Wenfei%20Zhao",
"affiliation": {
"@type": "Organization",
"name": "Department of Respiratory, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China."
}
},
{
"@type": "Person",
"name": "Hongyun Li",
"url": "https://questionsmedicales.fr/author/Hongyun%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Respiratory, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China."
}
},
{
"@type": "Person",
"name": "Shanshan Yang",
"url": "https://questionsmedicales.fr/author/Shanshan%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Respiratory, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China."
}
},
{
"@type": "Person",
"name": "Di Guo",
"url": "https://questionsmedicales.fr/author/Di%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Department of Respiratory, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China."
}
},
{
"@type": "Person",
"name": "Jing Chen",
"url": "https://questionsmedicales.fr/author/Jing%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Respiratory, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Psychometric Evaluation of a Measure of Evidence-Based Practice in Occupational Health.",
"datePublished": "2024-10-24",
"url": "https://questionsmedicales.fr/article/39450632",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23749/mdl.v115i5.16286"
}
},
{
"@type": "ScholarlyArticle",
"name": "Change in orthopaedic surgeon behaviour by implementing evidence-based practice.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37341352",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Reducing the incidence of stroke-associated pneumonia: an evidence-based practice.",
"datePublished": "2022-08-11",
"url": "https://questionsmedicales.fr/article/35953801",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12883-022-02826-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adaptation and validation of the Evidence-based Practice Profile Questionnaire (EBP",
"datePublished": "2023-08-21",
"url": "https://questionsmedicales.fr/article/37605185",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12909-023-04594-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Investigating the influencing factors of evidence-based healthcare practice adoption.",
"datePublished": "2024-09-12",
"url": "https://questionsmedicales.fr/article/39354780",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4102/curationis.v47i1.2586"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Cellules épithéliales",
"item": "https://questionsmedicales.fr/mesh/D004847"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cellules A549",
"item": "https://questionsmedicales.fr/mesh/D000072283"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cellules A549 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cellules A549",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cellules A549",
"description": "Comment identifier les cellules A549 en laboratoire ?\nQuelles techniques sont utilisées pour étudier les cellules A549 ?\nLes cellules A549 sont-elles tumorales ?\nPeut-on détecter des marqueurs spécifiques dans les A549 ?\nLes cellules A549 sont-elles sensibles à des médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Evidence-Based+Practice&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cellules A549",
"description": "Quels symptômes sont associés aux cellules A549 ?\nLes cellules A549 peuvent-elles simuler des symptômes humains ?\nComment les A549 aident-elles à comprendre les symptômes du cancer ?\nLes cellules A549 montrent-elles des signes de stress cellulaire ?\nPeut-on observer des symptômes de résistance dans les A549 ?",
"url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Evidence-Based+Practice&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cellules A549",
"description": "Les cellules A549 aident-elles à la prévention du cancer ?\nComment les A549 contribuent-elles à la recherche préventive ?\nPeut-on utiliser les A549 pour étudier des facteurs de risque ?\nLes A549 sont-elles utiles pour la recherche sur le tabagisme ?\nComment les A549 aident-elles à comprendre la prévention des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Evidence-Based+Practice&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cellules A549",
"description": "Quels traitements sont testés sur les cellules A549 ?\nLes A549 sont-elles utilisées pour des essais cliniques ?\nComment les A549 aident-elles à développer de nouveaux traitements ?\nLes cellules A549 peuvent-elles prédire la réponse au traitement ?\nQuels agents sont souvent testés sur les A549 ?",
"url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Evidence-Based+Practice&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cellules A549",
"description": "Quelles complications peuvent être étudiées avec les A549 ?\nLes A549 peuvent-elles simuler des complications pulmonaires ?\nComment les A549 aident-elles à comprendre les complications du cancer ?\nPeut-on étudier la résistance aux traitements avec les A549 ?\nLes A549 sont-elles impliquées dans des complications métaboliques ?",
"url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Evidence-Based+Practice&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cellules A549",
"description": "Quels facteurs de risque sont étudiés avec les A549 ?\nLes A549 aident-elles à identifier des facteurs génétiques ?\nComment les A549 sont-elles utilisées pour étudier l'environnement ?\nPeut-on étudier l'alimentation avec les A549 ?\nLes A549 sont-elles utiles pour étudier le stress oxydatif ?",
"url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Evidence-Based+Practice&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les cellules A549 en laboratoire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cellules A549 peuvent être identifiées par leur morphologie et leur croissance en culture."
}
},
{
"@type": "Question",
"name": "Quelles techniques sont utilisées pour étudier les cellules A549 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les techniques incluent la microscopie, la cytométrie en flux et les tests de viabilité cellulaire."
}
},
{
"@type": "Question",
"name": "Les cellules A549 sont-elles tumorales ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les cellules A549 proviennent d'un adénocarcinome, ce qui les rend tumorales."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des marqueurs spécifiques dans les A549 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des marqueurs comme le CD44 et le p53 peuvent être analysés dans les A549."
}
},
{
"@type": "Question",
"name": "Les cellules A549 sont-elles sensibles à des médicaments ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent utilisées pour tester la sensibilité aux chimiothérapies."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux cellules A549 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cellules A549 ne présentent pas de symptômes, car elles sont in vitro."
}
},
{
"@type": "Question",
"name": "Les cellules A549 peuvent-elles simuler des symptômes humains ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être utilisées pour étudier des symptômes liés aux maladies pulmonaires."
}
},
{
"@type": "Question",
"name": "Comment les A549 aident-elles à comprendre les symptômes du cancer ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'étudier la réponse des cellules tumorales aux traitements et aux facteurs de croissance."
}
},
{
"@type": "Question",
"name": "Les cellules A549 montrent-elles des signes de stress cellulaire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent montrer des signes de stress en réponse à des agents cytotoxiques."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes de résistance dans les A549 ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être utilisées pour étudier la résistance aux médicaments anticancéreux."
}
},
{
"@type": "Question",
"name": "Les cellules A549 aident-elles à la prévention du cancer ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, elles sont utilisées pour étudier les mécanismes de la carcinogenèse."
}
},
{
"@type": "Question",
"name": "Comment les A549 contribuent-elles à la recherche préventive ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'identifier des biomarqueurs et des cibles pour la prévention du cancer."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser les A549 pour étudier des facteurs de risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont utilisées pour étudier l'impact de divers facteurs environnementaux sur le cancer."
}
},
{
"@type": "Question",
"name": "Les A549 sont-elles utiles pour la recherche sur le tabagisme ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent utilisées pour étudier les effets du tabagisme sur les cellules pulmonaires."
}
},
{
"@type": "Question",
"name": "Comment les A549 aident-elles à comprendre la prévention des maladies ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'explorer les mécanismes de protection et les interventions préventives."
}
},
{
"@type": "Question",
"name": "Quels traitements sont testés sur les cellules A549 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements anticancéreux et les thérapies ciblées sont souvent testés sur ces cellules."
}
},
{
"@type": "Question",
"name": "Les A549 sont-elles utilisées pour des essais cliniques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles sont utilisées pour des études précliniques et non pour des essais cliniques directs."
}
},
{
"@type": "Question",
"name": "Comment les A549 aident-elles à développer de nouveaux traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'évaluer l'efficacité et la toxicité des nouveaux composés thérapeutiques."
}
},
{
"@type": "Question",
"name": "Les cellules A549 peuvent-elles prédire la réponse au traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent fournir des indications sur la réponse aux traitements, mais ne sont pas définitives."
}
},
{
"@type": "Question",
"name": "Quels agents sont souvent testés sur les A549 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des agents chimiothérapeutiques comme le cisplatine et des inhibiteurs de tyrosine kinase."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent être étudiées avec les A549 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'étudier les complications liées aux traitements du cancer et aux métastases."
}
},
{
"@type": "Question",
"name": "Les A549 peuvent-elles simuler des complications pulmonaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont utilisées pour modéliser des complications comme la fibrose pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment les A549 aident-elles à comprendre les complications du cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'étudier les interactions entre les cellules tumorales et le microenvironnement."
}
},
{
"@type": "Question",
"name": "Peut-on étudier la résistance aux traitements avec les A549 ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent utilisées pour comprendre les mécanismes de résistance aux traitements."
}
},
{
"@type": "Question",
"name": "Les A549 sont-elles impliquées dans des complications métaboliques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être utilisées pour étudier les effets métaboliques des traitements anticancéreux."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont étudiés avec les A549 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le tabagisme, l'exposition à des agents chimiques et la pollution."
}
},
{
"@type": "Question",
"name": "Les A549 aident-elles à identifier des facteurs génétiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être utilisées pour étudier l'expression génique liée à des prédispositions au cancer."
}
},
{
"@type": "Question",
"name": "Comment les A549 sont-elles utilisées pour étudier l'environnement ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'évaluer l'impact des toxines environnementales sur les cellules pulmonaires."
}
},
{
"@type": "Question",
"name": "Peut-on étudier l'alimentation avec les A549 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, elles peuvent être utilisées pour explorer l'impact des nutriments sur le cancer."
}
},
{
"@type": "Question",
"name": "Les A549 sont-elles utiles pour étudier le stress oxydatif ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent utilisées pour examiner les effets du stress oxydatif sur les cellules."
}
}
]
}
]
}
Occupational Health Services (OHS) are obliged to follow the principles of evidence-based medicine. However, there needs to be tools to measure this. Therefore, we developed and validated a questionna...
The questionnaire's content validity was assessed by 12 experts in the field. Then, an opportunity sample of 549 OHS practitioners completed the questionnaire. We examined the questionnaire's psychome...
The content validity index of the chosen items was 0.78 or higher. Exploratory factor analysis revealed that the measure's construct validity was adequate (KMO 0.9). Principal component factor analysi...
The EBP-OHS is a valid tool for measuring occupational health services' evidence-based practice and enabling the implementation of research into practice. It embodies the phases of evidence transfer a...
Orthopaedic practice is not always aligned with new evidence which may result in an evidence-practice gap. Our aim was to present and report the use of a new model for implementation of evidence-based...
A new implementation model from the Centre for Evidence-Based Orthopaedics (CEBO) was applied. It comprises four phases: 1) baseline practice is held up against best available evidence, and barriers t...
Prior to application of the CEBO model, only VLP was used in the department. Based on best evidence, the symposium found that a change in practice was justified. A local guideline stating CRPP as firs...
It is feasible to change surgeons' practice according to best evidence using the CEBO model....
None....
Not relevant....
Pulmonary infection is a frequent complication among stroke patients and adversely affects clinical outcomes, increases the length of hospitalization stay and costs, and aggravates the financial burde...
The evidence-based practice project evaluated the effectiveness of a standard care bundle intervention in preventing the occurrence of SAP....
The project was conducted in a neurology department of a teaching hospital. Given the variation in assessment and management standards, evidence-based practice (EBP) methodology was used to establish ...
A significant improvement was observed in preventing SAP in patients in the postimplementation group compared with those in the preimplementation group (14.0% vs. 37.2%, p = 0.025). In addition, signi...
Evidence-based care bundles successfully empower nurses to reduce the incidence of SAP. The management flow of SAP prevention could be promoted to other units of the neurology department in the future...
Evidence-based practice (EBP) is an essential approach of optimizing patient outcomes and driving progress in clinical practice. As an important reserve talent of medical staff and researchers, the cl...
Cross-cultural modification, including translating the original EBP...
The Chinese EBP...
Chinese version of EBP...
In healthcare facilities, evidence-based healthcare practice (EBHP) is becoming more widely acknowledged as a critical element of patient care delivery. An increasingly important component of EBHP is ...
This study aims to investigate factors that influence EBHP adoption in public healthcare institutions in South Africa....
Four hundred and fifty patients were self-administered to healthcare professionals at an academic public hospital in Gauteng and used in this study. A total of 300 responses were available for use in ...
Perceived ease of use (PEOU) and perceived usefulness (PU) were found to be major variables in the adoption of EBHP along with technological, organisational and environmental factors. The technology c...
Perceived ease of use, PU, ORGR, and GLRS are regarded as a vital variables in the implementation of EBHP in South African public hospitals.Contribution: The study's conclusions would be helpful to po...
The purpose of this study was to determine medical-surgical nurse leaders' evidence-based practice (EBP) attributes, perceived barriers to EBP, and whether there were differences in leaders' EBP compe...
Leaders are crucial to the development of cultures that support EBP implementation, but little is known about medical-surgical nurse leaders' capacity to perform this aspect of their role....
A cross-sectional design using survey methodology was used. The survey contained demographic/work setting questions and 3 instruments to measure EBP beliefs, implementation, and competencies....
Senior leaders self-reported higher EBP attributes compared with nurses in other roles; nurses with an MSN or higher reported greater frequency of EBP implementation. A regression revealed that EBP co...
Findings demonstrate there is a range of EBP beliefs and competencies, and barriers to EBP among medical-surgical nurse leaders. Because medical-surgical nursing is the largest acute care practice spe...
Nurse burnout is a well-defined problem that has been exacerbated by the coronavirus disease 2019 (COVID-19) pandemic and negatively affects nurses' mental health, nursing shortages, patient safety, a...
Evidence-based physiotherapy practice (EBPTP) is becoming increasingly important to improve patient outcomes and clinical decision-making in the physiotherapy profession....
To evaluate the EBPTP in Jordan and identify the barriers to its implementation in clinical practice....
The study used a cross-sectional survey of licensed physiotherapists working in Jordan using EBPTP self-reported questionnaire. Frequencies, percentages, and one sample Wilcoxon rank test were used to...
A total of 210 participants completed the survey. All EBPTP questionnaire elements showed significant positive levels (p = .00) except facility support reflecting non-significant negative level (p = ....
The findings confirm a clear gap in EBPTP implementation among physiotherapists in Jordan. The EBPTP implementation factors were mainly based on education sectors and work facilities. Engagement of st...
The aim of this scoping review was to identify and review current evidence-based practice (EBP) models and frameworks. Specifically, how EBP models and frameworks used in healthcare settings align wit...
A Scoping review....
Published articles were identified through searches within electronic databases (MEDLINE, EMBASE, Scopus) from January 1990 to April 2022. The English language EBP models and frameworks included in th...
Of the 20 097 articles found by our search, 19 models and frameworks met our inclusion criteria. The results showed a diverse collection of models and frameworks. Many models and frameworks were well ...
Many EBP models and frameworks currently exist that provide diverse instructions on the best way to use EBP. However, the inclusion of patient values and preferences needs to be better integrated into...
Following acute brain injury, patients in the intensive care unit often undergo hourly or every-other-hour exams ("neurochecks") to monitor for neurodeterioration. We assessed health care provider att...
This was a cross-sectional, online survey distributed in Spring 2021 at a tertiary care academic medical center. Providers from multiple intensive care unit and neuroscience clinical specialties inclu...
Among 177 participants, 61 (34%) and 116 (66%) were self-identified as ordering and performing providers, respectively. The survey response rate was 58% among physicians and 51% among bedside nurses w...
This survey revealed clinically relevant differences in ordering versus performing provider attitudes about frequent neurochecks. Providers preferred every-other-hour rather than hourly neurochecks....